Navigation Links
MicroAire and Arthrex Agree to Amicable Settlement on ECTR Patent
Date:11/9/2010

CHARLOTTESVILLE, Va., Nov. 9, 2010 /PRNewswire/ -- MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract.  At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.

Judge Norman K. Moon of the U.S. District Court for the Western District of Virginia approved the agreement on Thursday, October 28, without disclosing specific terms.  The two companies issued this joint statement expressing their commitment to the safety and efficacy of endoscopic carpal tunnel release, also known as ECTR.

As a result of the agreement, MicroAire will now license its patented ECTR technology to Arthrex for an undisclosed fee; and both companies will maintain MicroAire's practice of requiring surgeon training for this procedure.

Alan Connor, MicroAire's Vice President of Operations, expressed his satisfaction with the settlement, noting the emphasis on patient safety and surgeon training.  "MicroAire believes, as does Arthrex, that the endoscopic method of carpal tunnel release is a safe method that provides measurable patient benefits including a smaller scar, less pain and a faster recovery."

Anthony Cho, legal counsel for Arthrex, said, "Both Arthrex and MicroAire worked together in good faith to settle their differences amicably and should be commended for their efforts."

MicroAire's patented endoscopic treatment of carpal tunnel syndrome is a minimally invasive alternative to open-hand surgery.  Endoscopy enables visualization of the surgical procedure on a video monitor through the use of a tiny camera inserted into a small incision in the crease of the patient's wrist.  The treatment has been practiced for over twenty years and its safety and efficacy are supported by an impressive body of clinical data, including a randomized, prospective study involving more than 1,000 patients in 63 surgery centers.  (Agee, JM et al. "Endoscopic Release of the Carpal Tunnel: A Randomized Prospective Multicenter Study." Journal of Hand Surgery. 1992; 17(6):987-995)

MicroAire Surgical Instruments LLC, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas:  Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery.  MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes.  For more information, visit www.microaire.com.

Arthrex, headquartered in Naples, Florida, is a worldwide leader in sports medicine product development and educational services for orthopaedic surgeons.  Over 5,000 products for arthroscopic and minimally invasive orthopaedic surgical procedures have been developed by Arthrex and are currently marketed worldwide.  For more information, visit www.arthrex.com.Contact:D.J. Crotteau(434) 975-8389pr@microaire.com
'/>"/>

SOURCE MicroAire Surgical Instruments LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)
2. PLC Systems Signs TMR Asset Sale Agreement with Novadaq
3. Biotel, Inc. Announces Definitive Merger Agreement With CardioNet, Inc.
4. ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
5. Simbionix and AABIP Sign Collaboration Agreement
6. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
7. Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021
8. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
9. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
10. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
11. Pilgrim Software and Portford Solutions Sign Strategic Reseller Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... World Health Organization (WHO) expanded the Intended Use of the ... years, and above. Effective immediately, the PrePex device, manufactured by ... in the 14 priority countries in Southern and ... device to receive WHO Prequalification on 31 May 2013. ... The expanded use of PrePex for younger ages ...
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed ... stem cell therapy technology, protocols and patient results as have been achieved with ... a more accessible standard of care for patients worldwide. , As the Medical Advisory ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of experience, ... job, ensuring the best suited solution to meet regulatory requirements. Their professional staff ... lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is ... leader in the development of technological innovations that lead to broad-based healthcare solutions. ...
(Date:5/24/2016)... ... May 24, 2016 , ... WaterAid launched the #perioddrama campaign to mark ... than 1 billion women around the world who do not have access to a toilet, ... the US about their dread of #perioddrama. The (sometimes hilarious) results help shine a light ...
(Date:5/24/2016)... ... May 24, 2016 , ... Aloria ... Services To Begin In June , Aloria Health, specializing in a re-imagined, client-oriented ... of Aloria Milwaukee, its first treatment facility for outpatient, day treatment and residential ...
Breaking Medicine News(10 mins):